Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer
Metrics: HTML 1430 views | ?
Zi-Ran Wei1,*, Chao Liang1,*, Dan Feng2,*, Ya-Jun Cheng1, Wei-Min Wang1, De-Jun Yang1, Yue-Xiang Wang3, Qing-Ping Cai1
1Department of Gastro-Intestine Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China
2Department of Oncology, Changhai Hospital, Second Military Medical University, Shanghai, China
3SIBS (Institute of Health Sciences)-Changzheng Hospital Joint Center for Translational Medicine, Institute of Health Sciences, Shanghai Changzheng Hospital, Institutes for Translational Medicine (CAS-SMMU), Key Laboratory of Stem Cell Biology, Institute of Health Sciences, SIBS, Chinese Academy of Sciences/Shanghai JiaoTong University School of Medicine, Collaborative Innovation Center of Systems Biomedicine, Shanghai, China
*These authors have contributed equally to this work
Qing-Ping Cai, email: firstname.lastname@example.org
Yue-Xiang Wang, email: email@example.com
Keywords: tristetraprolin, pancreatic cancer, IL-6, Pim-1, prognosis
Received: July 14, 2015 Accepted: January 29, 2016 Published: February 15, 2016
Tristetraprolin (also known as TTP, TIS11, ZFP36, and Nup475) is a well-characterized tumor suppressor that is down-regulated in several tumor types. In the current study, we found that TTP expression was markedly reduced in pancreatic cancer samples as compared to matched normal tissues. Low TTP level was associated with age (P=0.037), tumor size (P=0.008), tumor differentiation (P=0.004), postoperative T stage (pT stage, P<0.001), postoperative N stage (pN stage, P=0.008) and TNM stage (P<0.001). Moreover, low TTP expression predicted reduced survival rates and poor patient outcome. We also found that TTP impairs pancreatic cancer cell proliferation both in vivo and in vitro. Fluorescence Activated Cell Sorting (FACS) assay showed that TTP over-expression both increases apoptosis and decreases proliferation in pancreatic cancer cells. RNA-sequencing analysis showed that TTP over-expression downregulates several tumor-related factors, including Pim-1 and IL-6. Our findings indicate that TTP could serve as a potential prognostic indicator in pancreatic cancer.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.